comparemela.com

Latest Breaking News On - Recent operating - Page 1 : comparemela.com

HashiCorp Announces First Quarter of Fiscal Year 2025 Financial Results

Firstquarter revenue totaled$160.6 million, representing an increase of16%year-over-year.Trailing four quarter average Net Dollar Retention Rate was113%at the end of thefirstquarter of fiscal2025as compared to127%at the end offirstquarter of fiscal2024.Firstquarter GAAP

San-francisco
California
United-states
Dave-mcjannet
Alex-kurtz
Kate-lehman
Nasdaq
Hashicorp-inc
International-business-machines
Ibm
Exchange-commission
Net-dollar-retention-rate

HashiCorp Announces First Quarter of Fiscal Year 2025 Financial Results

HashiCorp Announces First Quarter of Fiscal Year 2025 Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

San-francisco
California
United-states
Dave-mcjannet
Alex-kurtz
Kate-lehman
Ibm
Hashicorp-inc
Nasdaq
International-business-machines
Exchange-commission
Net-dollar-retention-rate

WiSA Technologies Reports Q1 2024 Results

- Expecting total of 8 WiSA E licensing agreements by year-end 2024, up from 5 currently - - First WiSA E-enabled products expected to contribute revenue in 2H 2024 - .

Canada
China
Beaverton
Ontario
Japan
California
United-states
Taiwan
Brett-moyer
Wisa-technologies-inc
Company-nasdaq
Samsung

Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights

Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Maryland
United-states
Utah
Salt-lake-city
American
Ignacio-guerrero-ros
Kevin-gardner
David-schull
Rob-etherington
Clene-nanomedicine
American-academy-of-neurology
Columbia-university

Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights

Initiated discussions with FDA regarding accelerated approval pathway for CNM-Au8® for the treatment of ALS with the objective of submitting an NDA in 2024Released long-term data from the open-label extension

National-institutes-of-health
Maryland
United-states
Utah
Salt-lake-city
Rob-etherington
Clene-nanomedicine
Clene-inc
Access-program
Natural-history-consortium
Securities-exchange
Linkedin

vimarsana © 2020. All Rights Reserved.